These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 1418026)
1. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Silver RM; McKinley K; Smith EA; Quearry B; Harati Y; Sternberg EM; Heyes MP Arthritis Rheum; 1992 Sep; 35(9):1097-105. PubMed ID: 1418026 [TBL] [Abstract][Full Text] [Related]
2. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. Silver RM; Sutherland SE; Carreira P; Heyes MP J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618 [TBL] [Abstract][Full Text] [Related]
3. L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine. Mainetti C; Fathi M; Saurat JH Dermatologica; 1991; 183(1):62-5. PubMed ID: 1722762 [TBL] [Abstract][Full Text] [Related]
4. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
5. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352 [TBL] [Abstract][Full Text] [Related]
6. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population. Bipath P; Levay PF; Viljoen M BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873 [TBL] [Abstract][Full Text] [Related]